The Antiepidermal Growth Factor Receptor Agent Gefitinib (ZD1839/Iressa) Improves Antihormone Response and Prevents Development of Resistance in Breast Cancer in Vitro
Year: 2003
Type: article
Source: Endocrinology
DOI: 10.1210/en.2003-0705
Language: English
Subfield: Endocrinology
Domain: Life Sciences
Open Access status: closed
Funders: AstraZeneca, Tenovus
OpenAlex ID: W2017021495
